Dr. Pailla Malla Reddy
Dr. Pailla Malla Reddy is a successful pharmaceutical entrepreneur with over 30 years of experience in the industry. He began his career working in various positions in pharmaceutical companies in India, Nigeria, and the United States. In 1995, Dr. Reddy founded Bactolac Pharmaceutical Inc, which is known today as an industry leading contract manufacturer of vitamins and supplements. He went on to found ScieGen Pharmaceuticals, Inc. in 2009. Under Dr. Reddy's eminent leadership, ScieGen continues to grow and become a leader in the generic manufacturing space. Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.
Dr. PaillaMalla Reddy is a successful pharmaceutical entrepreneur with over 30 years of experience in the industry. He began his career working in various positions in pharmaceutical companies in India, Nigeria, and the United States. In 1995, Dr. Reddy founded Bactolac Pharmaceutical Inc, which is known today as an industry leading contract manufacturer of vitamins and supplements. He went on to found ScieGen Pharmaceuticals, Inc. in 2009. Under Dr. Reddy's eminent leadership, ScieGen continues to grow and become a leader in the generic manufacturing space.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Mr. Reddy serves as Chief Operating Officer, bringing over two and a half decades of experience in the pharmaceutical industry in new product development, pre-formulations, analytical R&D, and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President at Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids, and Parenterals. Mr. Reddy has also spent over 12 years with Dr. Reddy’s Laboratoriesas the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, and EU drug filings throughout the USA, Canada, and Europe and has several patents (the US and WO).He has also written several publications. Mr. Reddy holds an MS degree in Pharmacy from Dr. MGR Medical University in India.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Subba Reddy is the Associate Vice President and Head of Manufacturing Operations. He is responsible for the manufacturing and supply of pharmaceutical products, and leads a team of over 250 employees.
Mr. Reddy joined ScieGen in October, 2016 as Senior Director, and has extensive manufacturing background in achieving significant performance improvement with regards to deliveries, projects, and safety.
Prior to joining ScieGen, Mr. Reddy worked as a Manufacturing Plant Site Head atDr. Reddy’s Laboratories, Head of Operations atWockhardt, and Head of Production at Cipla. He has over 30 years of experience in the industry, and holds hold a bachelor degree in Pharmacy and management leadership certifications.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Mr. Reddy joined ScieGen in October, 2016 as Senior Director, and has extensive manufacturing background in achieving significant performance improvement with regards to deliveries, projects, and safety.
Prior to joining ScieGen, Mr. Reddy worked as a Manufacturing Plant Site Head atDr. Reddy’s Laboratories, Head of Operations atWockhardt, and Head of Production at Cipla. He has over 30 years of experience in the industry, and holds hold a bachelor degree in Pharmacy and management leadership certifications.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Mr. Reddy serves as Chief Operating Officer, bringing over two and a half decades of experience in the pharmaceutical industry in new product development, pre-formulations, analytical R&D, and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President at Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids, and Parenterals. Mr. Reddy has also spent over 12 years with Dr. Reddy’s Laboratoriesas the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, and EU drug filings throughout the USA, Canada, and Europe and has several patents (the US and WO).He has also written several publications. Mr. Reddy holds an MS degree in Pharmacy from Dr. MGR Medical University in India.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Dr. Pailla Malla Reddy
Chief Executive Officer
Dr. Pailla Malla Reddy (CEO) is a successful pharmaceutical entrepreneur,he got abundant experience in various positions and managed pharmaceutical companies in Lagos, Nigeria, India and USA. Dr Reddy founded Sciegen Pharmaceuticals Inc. in 2009.
Sciegen operates a facility in Hauppuage, NY. Dr Reddy has successfully launched and actively manages other leading pharmaceutical companies in the USA and other countries as a Director.
He also founded Bactolac Pharmaceutical, Inc. in 1995 and has grown the company exponentially over the years. He also operates other companies in Russia. Dr. Reddy holds a Ph.D in Chemistry from Kanpur University in India. Under the eminent leadership and futuristic vision of Dr. Pailla Malla Reddy Chemeca Drugs Private Limited is set on the journey of transformation into world class Active Pharmaceutical and intermediate manufacturing facility.
